1992
DOI: 10.1016/0196-0709(92)90117-c
|View full text |Cite
|
Sign up to set email alerts
|

c-myc oncogene copy number in squamous carcinoma of the head and neck

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
15
0
1

Year Published

1996
1996
2007
2007

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 13 publications
1
15
0
1
Order By: Relevance
“…We assessed, in parallel, c-MYC gene amplification, which has been previ- ously shown to be amplified in various tumor types including HNSCC. [14][15][16][17][18] In this report we provide the first evidence that CENP-F is amplified and overexpressed in a group of HNSCCs.…”
Section: Discussionmentioning
confidence: 89%
See 3 more Smart Citations
“…We assessed, in parallel, c-MYC gene amplification, which has been previ- ously shown to be amplified in various tumor types including HNSCC. [14][15][16][17][18] In this report we provide the first evidence that CENP-F is amplified and overexpressed in a group of HNSCCs.…”
Section: Discussionmentioning
confidence: 89%
“…[27][28][29] The frequency of c-MYC amplification in our series (17%) is on the upper range relative to previous studies that reported frequencies from 7% to 25%. [14][15][16][17][18] Half the tumors had c-MYC amplified at a low-level range from 1.6 to 3-fold. This low-level c-MYC amplification is consistent with previous reports in various tumor types.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…3q amplification has been identified in early tumor development. Although there are some reports of overexpression and/or amplification of several proto-oncogenes, such as bcl-2, ras and c-myc (Haughey et al, 1992;Kiaris et al, 1995;Teni et al, 2002), little is known about the molecular changes associated with tumorigenic transformation.…”
Section: Introductionmentioning
confidence: 99%